Source:http://linkedlifedata.com/resource/pubmed/id/20428062
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-4-29
|
pubmed:abstractText |
The reaction of 5-(1-adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5) with various aromatic aldehydes in ethanol or acetic acid yielded the corresponding 4-arylideneamino derivatives 6a-v. Treatment of the 4-(2,6-difluoro- and dichlorobenzylideneamino) derivatives 6o and 6q with 1-substituted piperazines, and formaldehyde solution in ethanol afforded good yields of the corresponding 5-(1-adamantyl)-4-(2,6-dihalobenzylideneamino-2-(4-substituted-1-piperazinylmethyl)-1,2,4-triazoline-3-thiones 7a-p. 5-(1-Adamantyl)-4-arylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thiones 8a-n, were similarly prepared via the reaction of the corresponding arylideneamino derivative with ethyl 4-piperidinecarboxylate and formaldehyde solution in ethanol. Compounds 6a-v, 7a-p and 8a-n were tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Several derivatives showed good or moderate activities, particularly against the tested Gram-positive bacteria. In addition, the in vivo anti-inflammatory activity of 21 compounds was determined using the carrageenan-induced paw oedema method in rats. Compounds 7d, 7g, 7i, 7j, 7l, 8c, 8e and 8l showed good or moderate dose-dependent activity in this area.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1420-3049
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2526-50
|
pubmed:dateRevised |
2010-12-15
|
pubmed:meshHeading |
pubmed-meshheading:20428062-Animals,
pubmed-meshheading:20428062-Anti-Bacterial Agents,
pubmed-meshheading:20428062-Anti-Inflammatory Agents,
pubmed-meshheading:20428062-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:20428062-Antifungal Agents,
pubmed-meshheading:20428062-Bacteria,
pubmed-meshheading:20428062-Candida albicans,
pubmed-meshheading:20428062-Candida tropicalis,
pubmed-meshheading:20428062-Male,
pubmed-meshheading:20428062-Rats,
pubmed-meshheading:20428062-Rats, Sprague-Dawley,
pubmed-meshheading:20428062-Triazoles
|
pubmed:year |
2010
|
pubmed:articleTitle |
Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and related derivatives.
|
pubmed:affiliation |
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|